U.S. Anemia Treatment Market Trends: Growth, Share, Value, Size, and Analysis By 2030

As per MarkNtel The U.S. Anemia Treatment Market size was valued at around USD 1.07 billion in 2024 and is projected to reach USD 1.98 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 10.14% during the forecast period, i.e., 2025-30.

U.S. Anemia Treatment Market Systems Market Insights:

The U.S. Anemia Treatment Market has substantial growth as a result of multiple factors such as accidents and increased surgical treatments, resulting in a growing incidence rate of blood disorders. This can be seen in iron deficiency, which is the most common reason behind anemia. For instance, the number of anemia diagnoses has been increasing due to the rise in the aging population, especially among elderly people, who might have a higher risk of chronic diseases, such as kidney disease and cancer. Both of these conditions have higher chances of anemia.

In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2026 to 2032, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

Explore the Insights – Download a Free Sample:  https://www.marknteladvisors.com/query/request-sample/us-anemia-treatment-market.html

U.S. Anemia Treatment Market Systems Market Segmentation:

By Disease Type

  • Iron Deficiency Anemia-Market Size & Forecast 2020-2030, (USD Million)
  • Sickle Cell Anemia-Market Size & Forecast 2020-2030, (USD Million)
  • Aplastic Anemia-Market Size & Forecast 2020-2030, (USD Million)
  • Vitamin Deficiency Anemia-Market Size & Forecast 2020-2030, (USD Million)

By Drug

  • Bone Marrow Stimulants- Market Size & Forecast 2020-2030, (USD Million)
  • Gene Therapy- Market Size & Forecast 2020-2030, (USD Million)
  • Corticosteroids- Market Size & Forecast 2020-2030, (USD Million)
  • Iron Chelating Agents-Market Size & Forecast 2020-2030, (USD Million)
  • Supplements-Market Size & Forecast 2020-2030, (USD Million)
  • Iron-Market Size & Forecast 2020-2030, (USD Million)
  • Vitamin B12-Market Size & Forecast 2020-2030, (USD Million)
  • Folic Acid-Market Size & Forecast 2020-2030, (USD Million)

By Region

  • North
  • East
  • Mid-West
  • South

U.S. Anemia Treatment Market Recent Development:

  • September 2024: Pfizer Inc. announced that it voluntarily withdrew all lots of OXBRYTA® (voxelotor) for the treatment of sickle cell disease (SCD) in all approved markets. Additionally, Pfizer discontinued all active voxelotor clinical trials and expanded access programs worldwide.

Tap into future trends and opportunities shaping the U.S. Anemia Treatment Market complete report: https://www.marknteladvisors.com/research-library/us-anemia-treatment-market.html

U.S. Anemia Treatment Market Drivers:

Growing Prevalence of Chronic Diseases in the United States – In the U.S., the growing incidence of chronic disease is drastically influencing the dynamics of the Anemia industry. These ailments cause the body to supply insufficient quantities of healthy red blood cells which ends up in anemia. As per the National Institute of Diabetes and Digestive and Kidney Diseases, around 15% of U.S. Adults, which is nearly 37 million, have chronic kidney disorder (CKD). Similarly, chemotherapy is a shape of most cancer treatments that regularly disrupt because of red blood cells, therefore causing anemia. According to the American Cancer Society, almost 1.9 million new cancer cases are diagnosed every year in the U.S., many requiring supportive anemia healing procedures for fatigue management. To meet this demand, erythropoiesis-stimulating agents (ESAs) are notably used to set off crimson blood cell manufacturing amongst patients stricken by CKD or whoever undergoing cancer remedy.

Report Highlights Essential Insights for Strategic Decision-Making

  • Detailed market size, share, and forecast analysis
    • In-depth pricing trends and segment-wise cost evaluations
    • Key industry strategiesincluding innovation, partnerships, and acquisitions
    • Critical value chain analysis and stakeholder profiling
    • Regional import-export market insights and trade flow assessment
    • Thorough competitive benchmarking of top hearing aid manufacturers
    • Identification of new growth opportunities and niche market segments
    • Overview of market trends, drivers, and challenges shaping future demand

Some of the leading players in the U.S. Anemia Treatment Market are:

  • Pfizer
  • Novartis
  • Roche
  • Amgen
  • Bayer
  • Teva Pharmaceuticals
  • AMAG Pharmaceuticals
  • Akebia Therapeutics
  • Janssen Pharmaceuticals, Inc.
  • Vifor Pharma Management Ltd.
  • Abbott
  • Sanofi and others.

Report Delivery Format – Market research reports from MarkNtel Advisors are delivered in PDF, Excel, and PowerPoint formats. Once the payment is successfully processed, the report will be sent to your registered email within 24 hours.

Select a License That Matches Your Business Requirements with Instant Offer - https://www.marknteladvisors.com/pricing/us-anemia-treatment-market.html

Research Methodology Summary

A systematic approach is used to ensure accurate market insights, combining both bottom-up and top-down methodsData triangulation validates findings from multiple angles.

Key Steps:

  • Define objectives and research design
  • Collect data through surveys and interviews
  • Analyze and validate data using reliable tools
  • Forecast trends and deliver actionable insights

About us:

MarkNtel Advisors is a globally recognized market research and consulting firm delivering intelligence across the healthcare industry, spanning pharmaceuticals, medical devices, healthcare IT, and biotechnology. Our analysts combine domain expertise with innovation tracking to help healthcare organizations improve efficiency and patient outcomes. Through Consulting Services, we assist clients in interpreting insights, designing go-to-market strategies, and adapting to regulatory changes, fostering sustainable growth in the evolving global healthcare ecosystem.

Trending blog:

Reach Us:

MarkNtel Advisors

Sector 63, Noida, Uttar Pradesh-201301, India

Contact No: +91 8719999009

Email: sales@marknteladvisors.com

Visit our Website: https://www.marknteladvisors.com

We’re always open to sharing insights, exploring ideas. Follow us to stay updated on the latest news and industry trends.

 

Спонсоры
Обновить до Про
Выберите подходящий план
Спонсоры
Больше